In Vitro Toxicology
In Vitro Toxicology analyses global in vitro toxicity testing markets and various market segments with the objective to identify the important market trends that will bring further growth in this market. The study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for various toxicity endpoint segments for 2018-2023, including ADME-Tox; cytotoxicity; genotoxicity; ocular toxicity; skin irritation, corrosion, and sensitization; dermal toxicity; carcinogenicity; phototoxicity; neurotoxicity; organ toxicity; and other endpoints and tests.
This report identifies key regional market trends in developed as well as emerging markets, which offer valuable insights to market players including technology companies and contract research organizations who are currently exploring expansion strategies to new geographic markets. The regional market insights are also beneficial for companies in various end-use industry segments to develop market entry strategies as well as outsourcing strategies by understanding the regional market and regulatory trends. In Vitro Toxicology provides market sizing and growth trends for 2018-2023 in North America, Europe, Asia Pacific and rest of world, breaking out this information by technology, by industry, by method and by products and services.
This report also identifies market drivers and restraints to assess how they are shaping the market and its future prospects. In addition, the study identifies major stakeholders and analyses their business strategies with respect to the market segments in which they are active. The report also profiles many leading and niche players of the market, including Charles River Laboratories (CRL), Eurofins Scientific and Thermo Fisher.